Lessons from type I interferons in ulcerative colitis.
Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. ak729@medschl.cam.ac.uk
Arthur
A
Kaser
Richard S
RS
Blumberg
D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007370:Interferon Type I / Q000276:immunology*; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use; D018793:Interleukin-13 / Q000276:immunology
D007370:Interferon Type I; D018793:Interleukin-13; D016899:Interferon-beta; D000068556:Interferon beta-1a
Immunity. 2002 Nov;17(5):629-38
12433369
Cytokine. 1998 Feb;10(2):75-81
9512896
J Clin Invest. 2004 May;113(10):1490-7
15146247
J Immunol. 1991 Oct 15;147(8):2518-24
1717564
Aliment Pharmacol Ther. 2008 Sep 15;28(6):758-67
19145731
Gastroenterology. 2003 May;124(5):1420-31
12730881
Annu Rev Immunol. 2010;28:573-621
20192811
Clin Gastroenterol Hepatol. 2005 Jun;3(6):581-6
15952100
Gut. 2003 Dec;52(12):1728-33
14633951
Gut. 2011 Apr;60(4):449-55
20971977
Science. 1990 Nov 2;250(4981):679-82
1700477
Eur J Gastroenterol Hepatol. 1995 Jul;7(7):597-602
8590152
Mucosal Immunol. 2009 Sep;2(5):393-402
19587641
Eur J Immunol. 1997 Oct;27(10):2650-6
9368622
Gut. 2003 Sep;52(9):1286-90
12912859